These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1601005)

  • 1. Corticosterone methyl oxidase type II deficiency: a cause of failure to thrive and recurrent dehydration in early infancy.
    Picco P; Garibaldi L; Cotellessa M; DiRocco M; Borrone C
    Eur J Pediatr; 1992 Mar; 151(3):170-3. PubMed ID: 1601005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisteroid analysis in children with terminal aldosterone biosynthesis defects.
    Peter M; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 1995 May; 80(5):1622-7. PubMed ID: 7745009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypoaldosteronism due to corticosterone methyl oxidase type II deficiency in two boys: metabolic and gas chromatography-mass spectrometry studies.
    Hauffa BP; Sólyom J; Gláz E; Shackleton CH; Wambach G; Vecsei P; Stolecke H; Homoki J
    Eur J Pediatr; 1991 Jan; 150(3):149-53. PubMed ID: 2044581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variability of corticosterone methyl oxidase (type II) deficiency. Presentation of three case reports].
    Rosendahl W; König M; Haack D; Vecsei P; Lewicka S
    Klin Padiatr; 1993; 205(3):180-4. PubMed ID: 8350592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous deletion of arginine-173 in the CYP11B2 gene in a girl with congenital hypoaldosteronism. Corticosterone methyloxidase deficiency type II.
    Peter M; Nikischin W; Heinz-Erian P; Fussenegger W; Kapelari K; Sippell WG
    Horm Res; 1998; 50(4):222-5. PubMed ID: 9838244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosterone methyl oxidase type II (CMO II) deficiency: biochemical approach to diagnosis.
    Yong AB; Montalto J; Pitt J; Oakes S; Preston T; Buchanan C
    Clin Biochem; 1994 Dec; 27(6):491-4. PubMed ID: 7697895
    [No Abstract]   [Full Text] [Related]  

  • 7. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosterone methyloxydase deficiency type II in a Croatian girl.
    Mardesić D; Sarnavka V; Dumić M; Stipić V
    J Endocrinol Invest; 1992 Mar; 15(3):197-9. PubMed ID: 1624680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired partial corticosterone methyl oxidase type II defect in diabetes mellitus. Case of hyperreninemic hypoaldosteronism.
    Braithwaite SS; Barbato AL; Emanuele MA
    Diabetes Care; 1990 Jul; 13(7):790-2. PubMed ID: 2167193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital hypoaldosteronism: the Visser-Cost syndrome revisited.
    Peter M; Sippell WG
    Pediatr Res; 1996 Mar; 39(3):554-60. PubMed ID: 8929880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene.
    Wasniewska M; De Luca F; Valenzise M; Lombardo F; De Luca F
    Eur J Endocrinol; 2001 Jan; 144(1):59-62. PubMed ID: 11174838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inborn error in the terminal step of aldosterone biosynthesis. Corticosterone methyl oxidase tpe II deficiency in a North American pedigree.
    Veldhuis JD; Kulin HE; Santen RJ; Wilson TE; Melby JC
    N Engl J Med; 1980 Jul; 303(3):117-21. PubMed ID: 6991942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation THR-185 ILE is associated with corticosterone methyl oxidase deficiency type II.
    Peter M; Bünger K; Sólyom J; Sippell WG
    Eur J Pediatr; 1998 May; 157(5):378-81. PubMed ID: 9625333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective aldosterone synthesis associated with hyperkalemic periodic paralysis.
    Allen DB
    Arch Neurol; 1993 Mar; 50(3):325-8. PubMed ID: 8442715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hook effect: a pitfall leading to misdiagnosis of hypoaldosteronism in an infant with pseudohypoaldosteronism.
    Akin L; Kurtoglu S; Kendirci M; Akin MA; Hartmann MF; Wudy SA
    Horm Res Paediatr; 2010; 74(1):72-5. PubMed ID: 20431271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical diagnosis and management of corticosterone methyl oxidase type II deficiency.
    Lee PD; Patterson BD; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1986 Jan; 62(1):225-9. PubMed ID: 3510001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosterone Methyl Oxidase Deficiency Type 1 with Normokalemia in an Infant.
    Üstyol A; Atabek ME; Taylor N; Yeung MC; Chan AO
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):356-9. PubMed ID: 27125267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 aldosterone synthase deficiency presenting in a middle-aged man.
    Kayes-Wandover KM; Schindler RE; Taylor HC; White PC
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1008-12. PubMed ID: 11238478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygosity for a mutation in the CYP11B2 gene in an infant with congenital corticosterone methyl oxidase deficiency type II.
    Jessen CL; Christensen JH; Birkebaek NH; Rittig S
    Acta Paediatr; 2012 Nov; 101(11):e519-25. PubMed ID: 22931312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.